Jacobs Levy Equity Management
PRAH

Jacobs Levy Equity Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Jacobs Levy Equity Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17,514
Closed -$2.2M – 1169
2020
Q4 		$2.2M Sell
17,514
-4,075
-19% -$456K 0.02% 564
2020
Q3 		$2.19M Buy
21,589
+2,209
+11% +$225K 0.02% 503
2020
Q2 		$1.89M Sell
19,380
-20,429
-51% -$1.9M 0.02% 545
2020
Q1 		$3.31M Buy
39,809
+22,129
+125% +$2.16M 0.04% 371
2019
Q4 		$1.97M Sell
17,680
-45,457
-72% -$4.68M 0.02% 546
2019
Q3 		$6.26M Sell
63,137
-27,334
-30% -$2.71M 0.08% 300
2019
Q2 		$8.97M Buy
90,471
+20,590
+29% +$1.97M 0.12% 210
2019
Q1 		$7.71M Buy
+69,881
New +$7.3M 0.11% 246
2018
Q2 		– Sell
-72,312
Closed -$6M – 1136
2018
Q1 		$6M Buy
72,312
+58,012
+406% +$5.15M 0.1% 255
2017
Q4 		$1.3M Buy
14,300
+7,180
+101% +$597K 0.02% 560
2017
Q3 		$542K Buy
+7,120
New +$538K 0.01% 688

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Jacobs Levy Equity Management's PRAH Position: Q1 2021 in Review

Jacobs Levy Equity Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 17,514 shares — an estimated $2.2M sold.

Jacobs Levy Equity Management first reported a position in PRAH in Q3 2017 and held it in 11 quarters. The position peaked at $8.97M in Q2 2019. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Jacobs Levy Equity Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 17,514 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $2.2M.
  • Jacobs Levy Equity Management first reported a position in PRA Health Sciences, Inc. in Q3 2017 and held it in 11 quarters.
  • Jacobs Levy Equity Management's PRA Health Sciences, Inc. position peaked at $8.97M in Q2 2019.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2021, filed 17 May 2021.